tiprankstipranks
Trending News
More News >
Sanara MedTech (SMTI)
:SMTI
US Market

Sanara MedTech (SMTI) Technical Analysis

Compare
36 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Sanara MedTech’s (SMTI) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Sanara MedTech is a Sell.
Sanara MedTech’s (SMTI) 20-Day exponential moving average is 29.18, while Sanara MedTech’s (SMTI) share price is $30.24, making it a Buy.
Sanara MedTech’s (SMTI) 50-Day exponential moving average is 29.77, while Sanara MedTech’s (SMTI) share price is $30.24, making it a Buy.

Sanara MedTech (SMTI) Pivot Points

Jul 11, 2025, 02:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
28.36
28.80
29.55
29.99
30.74
31.18
31.93
Fibonacci
28.80
29.25
29.54
29.99
30.44
30.73
31.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sanara MedTech (SMTI) Moving Averages

Jul 11, 2025, 02:07 AM
Period
Simple
Exponential
MA5
29.86Buy
29.78Buy
MA10
29.13Buy
29.37Buy
MA20
28.76Buy
29.18Buy
MA50
30.15Buy
29.77Buy
MA100
31.01Sell
30.71Sell
MA200
32.44Sell
31.74Sell
Sanara MedTech’s (SMTI) 10-Day exponential moving average is 29.37, while Sanara MedTech’s (SMTI) share price is $30.24, making it a Buy.
Sanara MedTech’s (SMTI) 100-Day exponential moving average is 30.71, while Sanara MedTech’s (SMTI) share price is $30.24, making it a Sell.
Sanara MedTech’s (SMTI) stock price is $30.24 and Sanara MedTech’s (SMTI) 50-day simple moving average is 30.15, creating a Buy signal.
Sanara MedTech’s (SMTI) stock price is $30.24 and Sanara MedTech’s (SMTI) 100-day simple moving average is 31.01, creating a Sell signal.
Sanara MedTech’s (SMTI) stock price is $30.24 and Sanara MedTech’s (SMTI) 200-day simple moving average is 32.44, creating a Sell signal.

Sanara MedTech (SMTI) Technical Indicators

Jul 11, 2025, 02:07 AM
Name
Value
Implied Action
RSI (14)
57.83
Neutral
STOCH (9,6)
73.57
Neutral
STOCHRSI (14)
79.14
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
24.12
Neutral
Williams %R
-17.07
Sell
CCI (14)
148.81
Sell
ATR (14)
1.19
-
Ultimate Oscillator
52.96
Neutral
ROC
8.70
Buy
Sanara MedTech’s (SMTI) Relative Strength Index (RSI) is 57.83, creating a Neutral signal.
Sanara MedTech’s (SMTI) Trend Strength Indicator (ADX) is 24.12, creating a Neutral signal.
Sanara MedTech’s (SMTI) Commodity Channel Index (CCI) is 148.81, creating a Sell signal.
Sanara MedTech’s (SMTI) Price Rate of Change (ROC) is 8.70, creating a Buy signal.

FAQ

Is SMTI a Buy, Hold, or Sell?
Based on SMTI’s technical indicators, SMTI is a Buy.
    What is SMTI’s RSI (14)?
    SMTI’s RSI (14) is 57.83, which suggests SMTI is a Neutral.
      What is SMTI’s MACD?
      SMTI’s MACD is 0.02, which suggests SMTI is a Sell.
        What is SMTI’s 5-day moving average?
        SMTI’s 5-day moving average is 29.86, which suggests SMTI is a Buy.
          What is SMTI’s 20-day moving average?
          SMTI 20-day moving average is 28.76, which suggests SMTI is a Buy.
            What is SMTI’s 50-day moving average?
            SMTI’s 50-day moving average is 30.15, which suggests SMTI is a Buy.
              What is SMTI’s 200-day moving average?
              SMTI’s 200-day moving average is 32.44, which suggests SMTI is a Sell.
                What is SMTI’s Williams % R (14)?
                SMTI’s Williams % R (14) is -17.07, which suggests SMTI is a Sell.
                  What is SMTI’s CCI (14)?
                  SMTI’s CCI (14) is 148.81, which suggests SMTI is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis